Inflammatory bowel disease (IBD) is an umbrella term used to describe a group of disorders characterised by chronic inflammation of the gastrointestinal tract, of which ulcerative colitis and Crohn’s disease are the most common. It is estimated that 500 000 people in the UK currently live with IBD. There are two peaks of incidence, the first of which is between 15 and 30 years of age, with a second smaller peak between 60 and 80 years of age. Its prevalence is ever increasing, and GPs play an important role in early diagnosis, which is the key in reducing the need for aggressive treatment.
Bar–MeirSChowersYLavyA, et al. (1998) Budesonide versus prednisone in the treatment of active Crohn’s disease. Gastroenterology115(4): 835–840. DOI: 10.1016/S0016-5085(98)70254-9.
BeckerJM (1999) Surgical therapy for ulcerative colitis and Crohn’s disease. Gastroenterology Clinics of North America28(2): 371–390. DOI: 10.1016/S0889-8553(05)70061-3.
6.
BestWR (2006) Predicting the Crohn's disease activity index from the Harvey-Bradshaw index. Inflammatory Bowel Diseases12(4): 304–310. DOI: 10.1097/01.MIB.0000215091.77492.2a.
7.
BestWRBecktelJMSingletonJW, et al. (1976) Development of a Crohn’s disease activity index. Gastroenterology70(3): 439–444. DOI: 10.1016/S0016-5085(76)80163-1.
8.
Beyer-BerjotLMaggioriLBirnbaumD, et al. (2013) A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis. Annals of Surgery258(2): 275–282. DOI: 10.1097/SLA.0b013e3182813741.
9.
FordACBernsteinCNKhanKJ, et al. (2011) Glucocorticosteroid therapy in Inflammatory bowel disease: Systematic review and meta-analysis. American Journal of Gastroenterology106(4): 590–599. DOI: 10.1038/ajg.2011.70.
10.
HarveyRFBradshawJM (1980) A simple index of Crohn’s-disease activity. The Lancet315(8167): 514–514. DOI: 10.1016/S0140-6736(80)92767-1.
LambCAKennedyNARaineT, et al. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut68(Suppl 3): s1–s106. DOI: 10.1136/gutjnl-2019-318484.
13.
LeeJAllenRAshleyS, et al. (2014) British Dietetic Association evidence-based guidelines for the dietary management of Crohn’s disease in adults. Journal of Human Nutrition and Dietetics27(3): 207–218. DOI: 10.1111/jhn.12176.
14.
LeeJMLeeK-M (2016) Endoscopic diagnosis and differentiation of inflammatory bowel disease. Clinical Endoscopy49(4): 370–375. DOI: 10.5946/ce.2016.090.
15.
NICE (2017) Bisphosphonates for treating osteoporosis. Available at: www.nice.org.uk/guidance/ta464 (accessed 1 May 2021).
Patel V, Wang Y, MacDonald JK, et al. (2014) Methotrexate for maintenance of remission in Crohn’s disease. Cochrane Database of Systematic Reviews 8: art. no.: CD006884. DOI: 10.1002/14651858.CD006884.pub3.
18.
Peyrin-BirouletLPanésJSandbornWJ, et al. (2016) Defining disease severity in inflammatory bowel diseases: Current and future directions. Clinical Gastroenterology and Hepatology14(3): 348–354.e17. DOI: 10.1016/j.cgh.2015.06.001.
RCGP (n.d.) Inflammatory bowel disease toolkit. Available at: www.rcgp.org.uk/ibd (accessed 9 May 2021).
22.
Sherlock ME, MacDonald JK, Griffiths AM, et al. (2015) Oral budesonide for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 10: art. no.: CD007698. DOI: 10.1002/14651858.CD007698.pub3.
23.
SipponenTSavilahtiEKolhoK-L, et al. (2008) Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings. Inflammatory Bowel Diseases14(1): 40–46. DOI: 10.1002/ibd.20312.
24.
TravisSPLDaneseSKupcinskasL, et al. (2014) Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: Results from the randomised CORE II study. Gut63(3): 433–441. DOI: 10.1136/gutjnl-2012-304258.
25.
Tripathi K and Feuerstein JD (2019) New developments in ulcerative colitis: Latest evidence on management, treatment, and maintenance. Drugs in Context 8: 1–11. DOI: 10.7573/dic.212572.
26.
TrueloveSCWittsLJ (1955) Cortisone in ulcerative colitis. British Medical Journal2(4947): 1041–1048. DOI: 10.1136/bmj.2.4947.1041.
27.
VagianosKBectorSMcConnellJ, et al. (2007) Nutrition assessment of patients with inflammatory bowel disease. Journal of Parenteral and Enteral Nutrition31(4): 311–319. DOI: 10.1177/0148607107031004311.
28.
YamamotoT (2005) Factors affecting recurrence after surgery for Crohn’s disease. World Journal of Gastroenterology11(26): 3971–3979. DOI: 10.3748/wjg.v11.i26.3971.
